Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma

Clinical trial NCT00512889 · COMPLETED

Trial details

NCT number: NCT00512889
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2007-08-01
Primary completion: 2011-02-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.